Overnight, room temperature hold of whole blood followed by 42-day storage of red blood cells in additive solution-7

Transfusion

Volumn 55, Issue 3, 2015, Pages 485-490

  Dumont, Larry J ^a   Cancelas, Jose A ^b   Maes, Lou Ann ^c   Rugg, Neeta ^b   Whitley, Pamela ^c   Herschel, Louise ^a   Siegal, Alan H ^a   Szczepiorkowski, Zbigniew M ^a   Hess, John R ^d   Zia, Majid ^e  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c AMERICAN RED CROSS   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e The Food System Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; LACTIC ACID; ADENINE; ADSOL; BUFFER; CITRATE PHOSPHATE DEXTROSE; CITRIC ACID; MANNITOL; SODIUM CHLORIDE; SOLUTION AND SOLUBILITY;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROCYTE PRESERVATION; HEMATOLOGICAL PROCEDURE; HUMAN; IN VITRO STUDY; NORMAL HUMAN; OVERNIGHT ROOM TEMPERATURE HOLD; PH; ROOM TEMPERATURE; BLOOD; BLOOD STORAGE; CELL SURVIVAL; CLINICAL TRIAL; COMPARATIVE STUDY; CYTOLOGY; DEVICES; DRUG EFFECTS; EVALUATION STUDY; HEMATOCRIT; LEUKAPHERESIS; MULTICENTER STUDY; OSMOLARITY; PHARMACOLOGY; PROCEDURES; SOLUTION AND SOLUBILITY; TEMPERATURE; TIME;

ADENINE; ADENOSINE TRIPHOSPHATE; BLOOD PRESERVATION; BUFFERS; CELL SURVIVAL; CITRATES; ERYTHROCYTES; GLUCOSE; HEMATOCRIT; HUMANS; HYDROGEN-ION CONCENTRATION; IN VITRO TECHNIQUES; LEUKOCYTE REDUCTION PROCEDURES; MANNITOL; OSMOLAR CONCENTRATION; PHARMACEUTICAL SOLUTIONS; SODIUM CHLORIDE; TEMPERATURE; TIME FACTORS;

EID: 84924413214     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12868     Document Type: Article

References (10)

1. Hess JR,. An update on solutions for red cell storage. Vox Sang 2006; 91: 13-19.
2. Hess JR, Rugg N, Joines AD, et-al. Buffering and dilution in red blood cell storage. Transfusion 2006; 46: 50-54.
3. Pietersz RNJ,. Storage of whole blood for up to 24 hours at ambient temperature before component preparation: implementation in the Netherlands. Transfusion 2011; 51: 3S-6S.
4. Cancelas JA, Dumont LJ, Maes LY, et-al. Additive solution-7 reduces the red blood cell cold storage lesion. Transfusion 2014. doi: 10.1111/trf.12867.
5. Dumont LJ, Cancelas JA, Maes LA, et-al. The bioequivalence of frozen plasma prepared from whole blood held overnight at room temperature compared to fresh-frozen plasma prepared within eight hours of collection. Transfusion 2014. doi: 10.1111/trf.12864.
6. Shinar E, Etlin S. Frendel O, Yahalom V,. The implementation of rapid cooling and overnight hold of whole blood at ambient temperature before processing into components in Israel. Transfusion 2011; 51: 58S-64S.
7. Levin E, Culibrk B, Gyongyossy-Issa MIC, et-al. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Transfusion 2008; 48: 2331-2337.
8. Thomas S,. Ambient overnight hold of whole blood prior to the manufacture of blood components. Transfus Med 2010; 20: 361-368.
9. Hogman CF, Engstrand L,. Factors affecting growth of Yersinia enterocolitica in cellular blood products. Transfus Med Rev 1996; 10: 259-275.
10. Jenkins C, Ramirez-Arcos S, Goldman M, et-al. Bacterial contamination in platelets: incremental improvements drive down but do not eliminate risk. Transfusion 2011; 51: 2555-2565.